HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methimazole embryopathy: delineation of the phenotype.

Abstract
We report on a further case of congenital anomalies in a child exposed to methimazole during the first trimester of pregnancy (from first to seventh gestational week), and define a specific malformation pattern related to prenatal methimazole exposure and consisting of choanal and esophageal atresia, scalp defects, minor facial anomalies and psychomotor delay.
AuthorsM Clementi, E Di Gianantonio, E Pelo, I Mammi, R T Basile, R Tenconi
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 83 Issue 1 Pg. 43-6 (Mar 05 1999) ISSN: 0148-7299 [Print] United States
PMID10076883 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antithyroid Agents
  • Teratogens
  • Methimazole
Topics
  • Abnormalities, Drug-Induced (genetics)
  • Adult
  • Antithyroid Agents (toxicity)
  • Child, Preschool
  • Choanal Atresia (chemically induced)
  • Esophageal Atresia (chemically induced)
  • Female
  • Graves Disease (drug therapy)
  • Humans
  • Male
  • Maternal-Fetal Exchange
  • Methimazole (toxicity)
  • Phenotype
  • Pregnancy
  • Pregnancy Trimester, First
  • Teratogens

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: